Thomas Ambrosi, assistant professor in the Department of Orthopaedic Surgery, has received a five-year, $3.7 million R01 grant from the National Institutes of Health to study a new way to repair cartilage damaged by osteoarthritis. Ambrosi, the principal investigator, will work with co-investigators J. Kent Leach, vice chair of research in orthopaedic surgery, and Nancy Lane, distinguished professor of medicine and rheumatology.
The project is funded by the National Institute on Aging. The team will study Growth factor-Enhanced Microfracture, or GEM, an approach that aims to activate the body's own skeletal stem cells and guide them toward producing healthy cartilage.
Osteoarthritis affects about 33 million U.S. adults according to the Centers for Disease Control and Prevention. The disease gradually breaks down cartilage, the tissue that cushions joints and helps them move smoothly.
"Unlike many other tissues, damaged articular cartilage has very limited capacity to repair itself, contributing to chronic pain and loss of mobility, particularly in patients with osteoarthritis," Ambrosi said. "It's a major challenge in treating the disease, and why this new approach is so exciting."

Harnessing the body's own stem cells
Ambrosi and his team study skeletal stem cells, the body's own repair cells for bone and cartilage. These cells can be activated by microfracture, a procedure in which surgeons make small holes into the bone beneath damaged cartilage to trigger healing.
The team's earlier research found that after microfracture, GEM can guide these stem cells to form hyaline cartilage — the smooth, durable tissue that normally covers joint surfaces. GEM works by adjusting both the cells' activity and their surrounding environment.
The approach has shown promising results in young animal studies but has been less effective in older mice. The new project will explore why aging limits the response and whether additional changes to the cellular environment can make GEM work in aged and osteoarthritic joints.
"Rather than introducing new cells or replacing damaged tissue, our goal is to overcome the barriers imposed by aging and disease by directing a patient's own skeletal stem cells to regenerate healthy cartilage, ultimately helping people maintain mobility and quality of life," Ambrosi said.
Leach notes that the project is an expansion of the leading-edge research already underway by the team to establish the power of skeletal stem cells in tissue regeneration.
"Dr. Ambrosi's award will identify druggable targets to activate the body's own cells within damaged tissue to regenerate cartilage. He approaches this project through the lens of aged and osteoarthritic disease states, which may reveal as yet unknown mechanisms to promote regeneration and restore quality of life," Leach said.
Rather than introducing new cells or replacing damaged tissue, our goal is to overcome the barriers imposed by aging and disease by directing a patient's own skeletal stem cells to regenerate healthy cartilage, ultimately helping people maintain mobility and quality of life."-Thomas Ambrosi, assistant professor, Department of Orthopaedic Surgery
Overcoming age-related barriers to cartilage repair
The project will examine biological changes linked to aging and osteoarthritis that may interfere with cartilage regeneration. Drawing on Ambrosi's expertise in skeletal stem cell biology, Leach's experience in regenerative medicine and biomaterials and Lane's clinical and translational expertise in osteoarthritis and age-related joint disease, the researchers will:
- Target FGF7. Earlier findings suggest that inflammation tied to aging and osteoarthritis raises levels of fibroblast growth factor 7, or FGF7, in skeletal stem cells and related cells. This may push the cells toward fibrosis, the formation of scar-like tissue, instead of healthy cartilage. The team will test whether blocking FGF7 during GEM treatment helps the stem cells produce hyaline cartilage in aged and osteoarthritic joints.
- Test a new compound. They will study whether a therapeutic compound identified in the Ambrosi lab can change how local skeletal stem cells behave and overcome age-related barriers to regeneration. Building on expertise in rheumatology and related preclinical models, the team will assess the compound's effectiveness in aged and osteoarthritic joints This will include its effects on inflammation, pain-related behaviors, gait and joint function.
- Map changes cell by cell. They will combine tissue-level assessments with single-cell technologies to track changes in the microenvironment, gene expression and molecular pathways during cartilage repair.
As a rheumatologist, I know that understanding how aging and inflammation slow cartilage regeneration will be key to helping our patients with osteoarthritis."-Nancy Lane, distinguished professor of Medicine and Rheumatology
A multidisciplinary UC Davis collaboration
The project brings together expertise in skeletal stem cell biology, osteoarthritis, inflammation, bioengineering and clinical medicine.
"This is very exciting and timely research," Lane said. "We know that the microenvironment of the bone-cartilage interface changes with aging, with the increased production of inflammatory cytokines and senescent cells that may either prevent or slow cartilage tissue regeneration. This study will examine the microenvironment at the single-cell level to inform us of the molecules that impact successful GEM treatment."
By identifying the biological factors that influence cartilage repair, the team hopes to lay the groundwork for GEM as a treatment that could one day help patients of different ages and stages of osteoarthritis rebuild cartilage with their own cells.
"As a rheumatologist, I know that understanding how aging and inflammation slow cartilage regeneration will be key to helping our patients with osteoarthritis," Lane said.
Dr. Ambrosi's award will identify druggable targets to activate the body's own cells within damaged tissue to regenerate cartilage." -J. Kent Leach, vice chair of research, Department of Orthopaedic Surgery
From Labs to Lives
This work is being supported by a grant from the National Institute on Aging (R01AG095155). Federal research funding helps transform promising discoveries into real-world breakthroughs that save lives and improve quality of life. Learn more about how public investment in UC Davis research powers innovation, strengthens the economy and advances human health in From Labs to Lives.


